These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 17652880)
21. Prevention of limb amputation in patients with limbs ulcers by autologous peripheral blood mononuclear cell implantation. Kawamura A; Horie T; Tsuda I; Ikeda A; Egawa H; Imamura E; Iida J; Sakata H; Tamaki T; Kukita K; Meguro J; Yonekawa M; Kasai M Ther Apher Dial; 2005 Feb; 9(1):59-63. PubMed ID: 15828908 [TBL] [Abstract][Full Text] [Related]
22. [A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia]. Gu Y; Zhang J; Qi L Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1017-20. PubMed ID: 17140078 [TBL] [Abstract][Full Text] [Related]
23. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells. Motukuru V; Suresh KR; Vivekanand V; Raj S; Girija KR J Vasc Surg; 2008 Dec; 48(6 Suppl):53S-60S; discussion 60S. PubMed ID: 19084740 [TBL] [Abstract][Full Text] [Related]
24. [Analysis of clinical state for arteriosclerosis obliterans in lower extremity of diabetic patients on peritoneal dialysis]. Shi JB; Sun QH; Nie JD; Sun LH; Zhang N; Han QF Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Feb; 45(1):109-13. PubMed ID: 23411531 [TBL] [Abstract][Full Text] [Related]
25. [Prognostic factors for critical limb ischemia after autologous bone marrow implantation]. Oda M; Kato K; Toba K; Otaki K; Kitajima T; Ikarashi N; Yanagawa T; Higashimura M; Asami F; Isoda M; Ozawa T; Moriyama M; Hirono S; Okura Y; Hanawa H; Kodama M; Aizawa Y J Cardiol; 2007 Oct; 50(4):235-42. PubMed ID: 17987839 [TBL] [Abstract][Full Text] [Related]
27. Therapeutic angiogenesis by autologous bone marrow cell implantation for refractory chronic peripheral arterial disease using assessment of neovascularization by 99mTc-tetrofosmin (TF) perfusion scintigraphy. Miyamoto M; Yasutake M; Takano H; Takagi H; Takagi G; Mizuno H; Kumita S; Takano T Cell Transplant; 2004; 13(4):429-37. PubMed ID: 15468685 [TBL] [Abstract][Full Text] [Related]
28. Enhancement of neovascularization with mobilized blood cells transplantaion: supply of angioblasts and angiogenic cytokines. Zhou B; Liu PX; Lan HF; Fang ZH; Han ZB; Ren H; Poon MC; Han ZC J Cell Biochem; 2007 Sep; 102(1):183-95. PubMed ID: 17390342 [TBL] [Abstract][Full Text] [Related]
29. Autologous peripheral blood stem cell transplantation to treat thromboangiitis obliterans: preliminary results. Wan J; Yang Y; Ma ZH; Sun Y; Liu YQ; Li GJ; Zhang GM Eur Rev Med Pharmacol Sci; 2016; 20(3):509-13. PubMed ID: 26914127 [TBL] [Abstract][Full Text] [Related]
30. [A FOLLOW-UP STUDY ON AUTOLOGOUS BONE MARROW MONONUCLEAR CELLS TRANSPLANTATION FOR CRITICAL LOWER ARTERIOSCLEROSIS OBLITERANS IN DIABETIC PATIENTS]. Dou Y; Zhao J; Zhang L; Wang X; Yuan H; Yuan C Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2015 Jul; 29(7):893-8. PubMed ID: 26540987 [TBL] [Abstract][Full Text] [Related]
36. [Arteriosclerosis obliterans (ASO)]. Koshikawa M; Ikeda U Nihon Rinsho; 2010 May; 68(5):926-9. PubMed ID: 20446594 [TBL] [Abstract][Full Text] [Related]
37. [Autologous peripheral blood stem cell transplantation for the treatment of lower extremity arterial occlusive disease]. Wang L; Dong SM; Jiang QZ; Nan JL; Liu YG; Li SR; Feng XM Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):345-8. PubMed ID: 16776930 [TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of granulocyte-colony-stimulating factor administration following autologous intramuscular implantation of bone marrow mononuclear cells: a randomized controlled trial in patients with advanced lower limb ischemia. Zafarghandi MR; Ravari H; Aghdami N; Namiri M; Moazzami K; Taghiabadi E; Fazel A; Pournasr B; Farrokhi A; Sharifian RA; Salimi J; Moini M; Baharvand H Cytotherapy; 2010 Oct; 12(6):783-91. PubMed ID: 20078390 [TBL] [Abstract][Full Text] [Related]
39. Application of autologous bone marrow mononuclear cells in six patients with advanced chronic critical limb ischemia as a result of diabetes: our experience. Subrammaniyan R; Amalorpavanathan J; Shankar R; Rajkumar M; Baskar S; Manjunath SR; Senthilkumar R; Murugan P; Srinivasan VR; Abraham S Cytotherapy; 2011 Sep; 13(8):993-9. PubMed ID: 21671823 [TBL] [Abstract][Full Text] [Related]
40. Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial. Lu D; Chen B; Liang Z; Deng W; Jiang Y; Li S; Xu J; Wu Q; Zhang Z; Xie B; Chen S Diabetes Res Clin Pract; 2011 Apr; 92(1):26-36. PubMed ID: 21216483 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]